Although the immediate added clinical value of the molecular classification is limited by its correlation with HR, HER2 status and tumor grade, the demonstration of differential gene expression profiles in these tumor types is providing a broader view of their phenotype that could reveal new type-specific therapeutic targets. Here, ERBB2 is linked to neoplasm.